IRIS UniCatt

Antonaci, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.519
EU - Europa 1.264
AS - Asia 1.174
SA - Sud America 211
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.460
SG - Singapore 619
NL - Olanda 357
IT - Italia 233
CN - Cina 210
BR - Brasile 171
SE - Svezia 158
FR - Francia 156
DE - Germania 107
VN - Vietnam 86
IE - Irlanda 60
GB - Regno Unito 48
JP - Giappone 40
ID - Indonesia 35
CA - Canada 31
IN - India 30
PL - Polonia 25
HK - Hong Kong 24
RU - Federazione Russa 24
FI - Finlandia 22
BD - Bangladesh 20
TR - Turchia 20
IQ - Iraq 17
MX - Messico 17
AR - Argentina 15
KR - Corea 14
ES - Italia 11
IR - Iran 10
RO - Romania 10
AT - Austria 8
BE - Belgio 8
ZA - Sudafrica 8
LT - Lituania 7
PA - Panama 7
PK - Pakistan 6
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
JO - Giordania 5
OM - Oman 5
SA - Arabia Saudita 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KZ - Kazakistan 4
UZ - Uzbekistan 4
VE - Venezuela 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
ME - Montenegro 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.199
Salva come PNG Salva come JPEG
Città #
Singapore 370
Amsterdam 348
Chandler 190
Ashburn 180
San Jose 180
New York 84
Rome 68
Beijing 47
Dublin 46
Los Angeles 46
Tokyo 35
Hefei 34
Jakarta 34
Lauterbourg 31
Milan 31
Munich 31
Tukwila 29
Dallas 26
Ho Chi Minh City 26
Boston 25
Frankfurt am Main 25
Marseille 25
Hong Kong 23
Princeton 21
San Mateo 19
Hanoi 18
Denver 17
Buffalo 16
Santa Clara 16
São Paulo 16
Warsaw 16
Chicago 15
Paris 15
The Dalles 15
Montreal 14
Moscow 14
Nuremberg 14
Orem 14
Seoul 14
Helsinki 12
Atlanta 11
Palermo 11
Ann Arbor 10
Houston 10
Bremen 9
London 9
Baghdad 8
Boardman 8
Council Bluffs 8
Düsseldorf 8
Kent 8
Portsmouth 8
Shanghai 8
Ankara 7
Brussels 7
Mexico City 7
Wilmington 7
Belo Horizonte 6
Hyderabad 6
Johannesburg 6
Memphis 6
Menlo Park 6
Poplar 6
Seattle 6
Stockholm 6
Amman 5
Brasília 5
Brescia 5
Chennai 5
Dhaka 5
Fairfield 5
Falkenstein 5
Haiphong 5
Kish 5
Lappeenranta 5
Salvador 5
Toronto 5
Washington 5
Wroclaw 5
Ahmedabad 4
Augusta 4
Bexley 4
Brooklyn 4
Charlotte 4
Da Nang 4
Florence 4
Gustavo Adolfo Madero 4
Las Vegas 4
Phoenix 4
Pittsburgh 4
Redwood City 4
Rio de Janeiro 4
Salt Lake City 4
Turku 4
Almaty 3
Ancona 3
Andover 3
Biên Hòa 3
Changsha 3
City of London 3
Totale 2.540
Salva come PNG Salva come JPEG
Nome #
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 503
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 160
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 157
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 154
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 151
Predominant distal muscle involvement in spinal muscular atrophy 148
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 135
Early treatment of type II SMA slows rate of progression of scoliosis 132
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 131
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients 129
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 127
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 127
Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy? 121
Sleep disorders in spinal muscular atrophy 117
New therapies for spinal muscular atrophy: where we stand and what is next 117
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 117
Clinical Variability in Spinal Muscular Atrophy Type III. 114
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 114
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 111
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 110
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 108
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study 105
Development of an academic disease registry for spinal muscular atrophy 105
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 103
P.222Long term progression in type II spinal muscular atrophy: a retrospective observational study 102
Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019 94
Long term follow-up of scoliosis progression in type II SMA patients 93
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 93
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1) 91
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 88
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 83
Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study 83
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 79
Italian validation of the SMA independence scale–upper limb module 39
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen 7
Neurodevelopmental and mental disorders in children with type I and presymptomatic spinal muscular atrophy 6
Expressive language and social communication abilities in children with spinal muscular atrophy type 1 2
Totale 4.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022241 14 4 5 44 18 8 6 31 18 16 38 39
2022/2023537 50 78 31 86 29 66 30 50 75 5 20 17
2023/2024383 7 82 12 35 12 80 28 23 1 30 34 39
2024/2025796 12 14 53 41 70 42 46 24 119 86 161 128
2025/20262.255 252 38 110 260 364 439 341 80 100 124 118 29
Totale 4.256